Yehud, Israel

Yarden Degani

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yarden Degani: Innovator in Hybrid Muco-Adhesive Delivery Systems

Introduction

Yarden Degani is a notable inventor based in Yehud, Israel. He has made significant contributions to the field of therapeutic and diagnostic agent delivery systems. His innovative work focuses on enhancing the effectiveness of drug administration through advanced delivery methods.

Latest Patents

Yarden holds 1 patent for his invention titled "Hybrid muco-adhesive delivery systems and use thereof." This patent describes a composition and method for administering therapeutic and diagnostic agents. Specifically, it details a hybrid system composed of a polymer that harbors drug-loaded lipid nanoparticles. This system is particularly useful for the administration of active agents, such as anti-cancer agents.

Career Highlights

Yarden Degani is associated with the Technion Research & Development Foundation Ltd. His work at this esteemed institution has allowed him to explore and develop innovative solutions in drug delivery systems. His research has the potential to significantly impact the medical field, particularly in cancer treatment.

Collaborations

Yarden collaborates with esteemed colleagues, including Shlomit Avidan-Shlomovich and Avi Schroeder. These partnerships enhance the research and development of his innovative projects.

Conclusion

Yarden Degani's contributions to hybrid muco-adhesive delivery systems exemplify the importance of innovation in the medical field. His work not only advances therapeutic methods but also holds promise for improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…